Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).
about
Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS.Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired PneumoniaInfluence of Moxifloxacin on Hepatic Redox Status and Plasma Biomarkers of Hepatotoxicity and Nephrotoxicity in Rat.Antibiotic Consumption During a 4-year Period in a Community Hospital with an Antimicrobial Stewardship Program.A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
P2860
Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@ast
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@en
type
label
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@ast
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@en
prefLabel
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@ast
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@en
P2093
P2860
P356
P1476
Efficacy and safety of moxiflo ...... observational study (CAPRIVI).
@en
P2093
Alexandr Bezlepko
Hans-Peter Marschall
Ilija Kuzman
Irena Kondova Topuzovska
Liudmyla Iudina
László Rókusz
Thomas Petri
P2860
P2888
P356
10.1186/1471-2466-14-105
P577
2014-06-30T00:00:00Z
P5875
P6179
1047818745